$VRSK

Mann Elizabeth sold $74K of VRSK

Mann Elizabeth (Chief Financial Officer) sold 400 shares of Verisk Analytics, Inc. (VRSK) at $184.85 on 2026-10-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mann Elizabeth
Published Oct 16, 2026, 8:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 16, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VRSK
Bearish
high confidence
Mentioned
$VRSK
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKBearishLow
01

Why it matters

The transaction is modest in size and unlikely to move the stock significantly, but it adds to the cumulative insider selling data that traders may track.

02

Market read

A small insider sell by the CFO, disclosed via Form 4, offers limited trading insight but may be a data point for monitoring insider trends.

03

What to watch

Potential tax‑loss harvesting or portfolio rebalancing motives behind the 10b5‑1 sale are not disclosed.

Relevance 2/10Novelty 2/10Timing: post‑market filing

Background

Form 4 filings disclose insider transactions; a CFO sale via a pre‑arranged plan is routine but noteworthy for investors monitoring insider activity.

Company-level read

Ticker impact

$VRSKBearishHigh confidence
Context

CFO Mann Elizabeth sold 400 shares for $73,940 via a 10b5-1 plan, reducing her holdings to 17,584 shares.

Expected impact

likely modest pressure as the market prices in the insider sale

Evidence & confidence

The sale is small relative to market cap and disclosed through a Form 4, indicating a routine transaction with limited market impact.

Market effects

Minimal effect on the data‑analytics sector; no broader industry signal.

No regional impact beyond standard market reaction to insider activity.

Limited global relevance; confined to VRSK investors.

Counterpoint

The sale could be interpreted as a signal of upcoming negative news, prompting a short‑term pullback.

Key entities

  • Verisk Analytics, Inc.

    Provider of data analytics and risk assessment solutions, ticker VRSK.

  • Mann Elizabeth

    Chief Financial Officer of Verisk Analytics.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VRSKHighAI 8/10

RBC Capital reiterates Verisk Analytics stock rating at Outperform

RBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).